benserazide

Also known as Madopar®, Ro 4-4602, serazide, Ro 44602, DL-serine 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide, DL-serine 2-(2,3,4-trihydroxybenzyl)hydrazide, benserazida, benserazidum

Benserazide is a peripherally acting aromatic L-amino acid decarboxylase or DOPA decarboxylase inhibitor, which is unable to cross the blood–brain barrier.

Key facts

Drug.Watchedfields: changed
Drug.verifiedrevid: 431818918
Drug.image: Benserazid.svg
Drug.image_class: skin-invert-image
Drug.image2: Benserazide ball-and-stick.png
Drug.image_class2: bg-transparent
Drug.pregnancy_AU: B3
Drug.ATC_prefix: None
Drug.index2_label: as HCl
Drug.CAS_number: 322-35-0
Drug.CAS_number2: 14919-77-8
Drug.PubChem: 2327
Drug.IUPHAR_ligand: 5150
Drug.DrugBank: DB12783
Drug.DrugBank2: DBSALT002687
Drug.ChemSpiderID: 2237
Drug.ChemSpiderID2: 25109
Drug.UNII: 762OS3ZEJU

via Wikipedia infobox

Research

1,641 papers

via PubMed

~2 min read

Encyclopedic overview

3 sections

Contents

Medical uses
Pharmacology
References

Benserazide is a peripherally acting aromatic L-amino acid decarboxylase or DOPA decarboxylase inhibitor, which is unable to cross the blood–brain barrier.

Benserazide is a therapeutic alternative on the World Health Organization's List of Essential Medicines.

Excerpted from Wikipedia’s “benserazide” article, available under the CC BY-SA 4.0 licence.

Available in 13 languages

via Wikidata sitelinks · CC0